A carregar...

Structure-based drug design identifies novel LPA(3) antagonists

Compound 5 ([5-(3-nitrophenoxy)-1,3-dioxo-1,3-dihydro-2-isoindol-2-yl]acetic acid) was identified as a weak selective LPA(3) antagonist (IC(50)=4504 nM) in a virtual screening effort to optimize a dual LPA(2&3) antagonist. Structure-based drug design techniques were used to prioritize similarity...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Fells, James I., Tsukahara, Ryoko, Liu, Jianxiong, Tigyi, Gabor, Parrill, Abby L.
Formato: Artigo
Idioma:Inglês
Publicado em: 2009
Assuntos:
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC2771199/
https://ncbi.nlm.nih.gov/pubmed/19800804
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.bmc.2009.09.022
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!